Yohei Yamauchi: Catalogue data in Autumn Semester 2023 |
| Name | Prof. Dr. Yohei Yamauchi |
| Field | Molecular Medicine |
| Address | Professur für Molekulare Medizin ETH Zürich, HCI H 305 Vladimir-Prelog-Weg 1-5/10 8093 Zürich SWITZERLAND |
| Telephone | +41 44 633 25 54 |
| yohei.yamauchi@pharma.ethz.ch | |
| Department | Chemistry and Applied Biosciences |
| Relationship | Full Professor |
| Number | Title | ECTS | Hours | Lecturers | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 535-0001-00L | Introduction to Pharmaceutical Sciences I  | 2 credits | 2V | J. Hall, S.‑D. Krämer, J.‑C. Leroux, B. Pfeiffer, U. Quitterer, J. Scheuermann, R. Schibli, Y. Yamauchi, H. U. Zeilhofer | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Abstract | First identification with Pharmaceutical Sciences; motivation for profiling in the Natural Sciences, which are focused on within the first two years as a preparation for the specialized studies; sensitization for the duties and the responsibilities of a person with a federal diploma in Pharmacy; information about job opportunities. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Learning objective | First identification with Pharmaceutical Sciences; motivation for profiling in the Natural Sciences as a preparation for the specialized studies; sensitization for the duties and the responsibilities of a person with a federal diploma in Pharmacy; information about job opportunities. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Content | Introduction to Pharmaceutical Sciences by selected milestones of research and development. Overview on research activities at the Institute of Pharmaceutical Sciences that is focussed on drug delivery and development (from concepts to prototypes). Sensitization for communication skills and information management. Demonstration of job opportunities in community pharmacies, in the hospital, in industry, and in the public sector by experts in the different fields. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Lecture notes | Handouts for individual lectures. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Prerequisites / Notice | Interactive teaching | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| 535-0041-00L | Pharmacology and Toxicology III | 2 credits | 2G | U. Quitterer, M. Arand, Y. Yamauchi | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Abstract | The course is divided into two parts. The first part provides a detailed understanding of drugs and the pharmacotherapy of infectious diseases and cancer. The second part gives an overview of the field of pharmacogenomics and toxicogenomics with a special focus on the role of genetic polymorphisms in disease susceptibility, drug response and adverse effects. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Learning objective | The course advances basic knowledge in pharmacology and toxicology. Special emphasis is placed on the interrelationship between pharmacological, pathophysiological and clinical aspects of drug therapy in the fields of infectious diseases and cancer. The course also provides an overview of the field of pharmacogenomics and toxicogenomics, with a special focus on the role of genetic polymorphisms in disease susceptibility, drug response and adverse effects. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Content | Topics include the pharmacology and pharmacotherapy of infectious diseases and cancer. In the field of pharmacogenomics and toxicogenomics, the course is focused on genetics, genome-wide association studies, examples of genetic variability of drug metabolism and drug responses, and the relevance of pharmacogenomics and toxicogenomcis for clinical drug development. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Lecture notes | A script is provided for each lecture. The scripts define important and exam-relevant contents of the lectures. Scripts do not replace the lectures. | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Literature | Recommended reading: The classic textbook in Pharmacology: Goodman and Gilman`s The Pharmacological Basis of Therapeutics Laurence Brunton, Bjorn C. Knollman. 14th edition (2022) ISBN-10: 1264258070 ISBN-13: 978-1264258079 or Klaus Aktories, Veit Flockerzi, Ulrich Förstermann, Franz Hofmann. Allgemeine und spezielle Pharmakologie und Toxikologie. 13th edition (2022) Urban & Fischer (Elsevier) ISBN-13: 978-3-437-42622-3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Competencies |
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||